Redhawk Wealth Advisors’s Halozyme HALO Stock Holding History

Redhawk Wealth Advisors’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.32M	Sell	29,690 -3,171	-10%	-$216K	0.23%	109
2026 Q1	$2.12M	Sell	32,861 -3,156	-9%	-$222K	0.23%	107
2025 Q4	$2.42M	Sell	36,017 -558	-2%	-$37.5K	0.27%	95
2025 Q3	$2.68M	Sell	36,575 -844	-2%	-$56.1K	0.31%	77
2025 Q2	$1.95M	Buy	37,419 +4,827	+15%	+$275K	0.24%	91
2025 Q1	$2.08M	Sell	32,592 -5,443	-14%	-$316K	0.28%	72
2024 Q4	$1.82M	Buy	38,035 +1,267	+3%	+$65K	0.25%	83
2024 Q3	$2.1M	Buy	36,768 +1,155	+3%	+$66.2K	0.3%	78
2024 Q2	$1.86M	Buy	+35,613	New	+$1.56M	0.29%	77

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Redhawk Wealth Advisors's HALO Position: Q2 2026 in Review

Redhawk Wealth Advisors reduced its Halozyme (HALO) stake by 9.6% in Q2 2026, selling an estimated $216K and leaving 29,690 shares worth $2.32M. The position accounts for 0.23% of the portfolio, ranked #109.

Redhawk Wealth Advisors first reported a position in HALO in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.68M in Q3 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Redhawk Wealth Advisors held 29,690 shares of Halozyme worth $2.32M as of Q2 2026.
Redhawk Wealth Advisors sold 3,171 Halozyme shares in Q2 2026, an estimated $216K.
Halozyme made up 0.23% of Redhawk Wealth Advisors's portfolio in Q2 2026, its #109 holding.
Redhawk Wealth Advisors first reported a position in Halozyme in Q2 2024 and has held it in 9 quarters since.
Redhawk Wealth Advisors's Halozyme position peaked at $2.68M in Q3 2025.
671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Redhawk Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.